ATE230991T1 - Verwendung von tetrahydropyridinderivaten zur herstellung von kardioprotektiven medikamenten - Google Patents

Verwendung von tetrahydropyridinderivaten zur herstellung von kardioprotektiven medikamenten

Info

Publication number: ATE230991T1
Authority: AT; Austria
Prior art keywords: producing; cardioprotective; tetrahydropyridine derivatives; medications; cardioprotective medications
Prior art date: 1993-03-18

Application number

AT94400597T

Other languages

English (en)

Inventor

Allan Stewart Manning

Pierre Paul Chatelain

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-18

Filing date

1994-03-18

Publication date

2003-02-15

1994-03-18 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2003-02-15 Application granted granted Critical

2003-02-15 Publication of ATE230991T1 publication Critical patent/ATE230991T1/de

Links

230000003293 cardioprotective effect Effects 0.000 title abstract 2
239000003814 drug Substances 0.000 title abstract 2
VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical class C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
229940079593 drug Drugs 0.000 title 1
125000004924 2-naphthylethyl group Chemical group C1=C(C=CC2=CC=CC=C12)CC* 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)

AT94400597T 1993-03-18 1994-03-18 Verwendung von tetrahydropyridinderivaten zur herstellung von kardioprotektiven medikamenten ATE230991T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9303149A FR2702656B1 (fr)	1993-03-18	1993-03-18	Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.

Publications (1)

Publication Number	Publication Date
ATE230991T1 true ATE230991T1 (de)	2003-02-15

Family

ID=9445120

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94400597T ATE230991T1 (de)	1993-03-18	1994-03-18	Verwendung von tetrahydropyridinderivaten zur herstellung von kardioprotektiven medikamenten

Country Status (9)

Country	Link
US (1)	US5378709A (de)
EP (1)	EP0615755B1 (de)
JP (1)	JP2650847B2 (de)
AT (1)	ATE230991T1 (de)
DE (1)	DE69432000T2 (de)
DK (1)	DK0615755T3 (de)
ES (1)	ES2191022T3 (de)
FR (1)	FR2702656B1 (de)
SG (1)	SG48784A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5891465A (en) *	1996-05-14	1999-04-06	Biozone Laboratories, Inc.	Delivery of biologically active material in a liposomal formulation for administration into the mouth
FR2772614B1 (fr) *	1997-12-24	2000-03-10	Sanofi Sa	Solution aqueuse a base de chlorhydrate de 1- [ 2-(2-naphtyl)ethyl]-4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine et composition pharmaceutique buvable en contenant
CZ20031262A3 (en) *	2000-10-16	2004-03-17	Neopharm, Inc.	Liposomal formulation of mitoxantrone
US20090076048A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched xaliproden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2639226B1 (fr) *	1988-11-18	1993-11-05	Sanofi	Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2650505B1 (fr) *	1989-08-07	1994-06-03	Midy Spa	Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
GB8919661D0 (en) *	1989-08-31	1989-10-11	Univ Alberta	Superoxide dismutase-catalase conjugates
FR2662355B1 (fr) *	1990-05-22	1994-11-10	Sanofi Sa	Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
FR2672213B1 (fr) *	1991-02-05	1995-03-10	Sanofi Sa	Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.

1993
- 1993-03-18 FR FR9303149A patent/FR2702656B1/fr not_active Expired - Fee Related
1994
- 1994-03-17 JP JP6047391A patent/JP2650847B2/ja not_active Expired - Fee Related
- 1994-03-17 US US08/214,307 patent/US5378709A/en not_active Expired - Lifetime
- 1994-03-18 AT AT94400597T patent/ATE230991T1/de not_active IP Right Cessation
- 1994-03-18 ES ES94400597T patent/ES2191022T3/es not_active Expired - Lifetime
- 1994-03-18 SG SG1996001628A patent/SG48784A1/en unknown
- 1994-03-18 EP EP94400597A patent/EP0615755B1/de not_active Expired - Lifetime
- 1994-03-18 DK DK94400597T patent/DK0615755T3/da active
- 1994-03-18 DE DE69432000T patent/DE69432000T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0615755A1 (de)	1994-09-21
EP0615755B1 (de)	2003-01-15
US5378709A (en)	1995-01-03
JPH06340628A (ja)	1994-12-13
SG48784A1 (en)	1998-05-18
DE69432000D1 (de)	2003-02-20
DK0615755T3 (da)	2003-03-17
ES2191022T3 (es)	2003-09-01
FR2702656B1 (fr)	1995-06-16
FR2702656A1 (fr)	1994-09-23
JP2650847B2 (ja)	1997-09-10
DE69432000T2 (de)	2003-09-04

Similar Documents

Publication	Publication Date	Title
AU589029B2 (en)	1989-09-28	Alpha-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments
ATE120644T1 (de)	1995-04-15	Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
NO174806C (de)	1994-07-13
AU3822293A (en)	1993-11-04	Cyclic imino derivatives
ATE79257T1 (de)	1992-08-15	Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE132861T1 (de)	1996-01-15	Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE69420679D1 (de)	1999-10-21	Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
DE69432000D1 (de)	2003-02-20	Verwendung von Tetrahydropyridinderivaten zur Herstellung von Kardioprotektiven Medikamenten
PT80670A (de)	1985-07-01	Neue 8-alkylthio-2-piperazino-pyrimido<5,4d>pyrimidine ihre herstellung und diese verbindungen enthaltende arzneimittel
ZA933455B (en)	1993-12-14	Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ATE88892T1 (de)	1993-05-15	Verwendung von trifluormethylphenyltetrahydropyridinen zur herstellung von arzneimitteln zur bekaempfung intestinaler motilitaetsstoerungen.
DE69014730D1 (de)	1995-01-19	(1,2,3,4-Tetrahydro-9-acridinimino)cyclohexan-Carbonsäure und verwandte Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
ATE143957T1 (de)	1996-10-15	Aminoalkylchomone, verfahren für ihre herstellung und die enthaltende pharmazeutische zusammensetzungen
DE3865362D1 (de)	1991-11-14	Derivat von benzo(b)thiophen-7-carboxylsaeure, verfahren zu dessen herstellung und dieses enthaltende arzneimittel.
GR3021200T3 (en)	1996-12-31	(Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them.
HU9202484D0 (en)	1992-10-28	Method for producing medical preparatives containing 1,4-dihydro-pyridine derivatives
DE59201085D1 (de)	1995-02-09	Neue p-Oxibenzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ATE170187T1 (de)	1998-09-15	Pyrrolothienopyrazin-verbindungen als 5ht3- rezeptoren-antagonisten
WO2000018732A3 (de)	2000-05-25	Disubstituierte pyrrolidinone, diese verbindungen enthaltende arzneimittel und deren verwendung sowie ihre herstellung

Legal Events

Date

Code

Title

Description

2003-08-15

UEP

Publication of translation of european patent specification

Ref document number: 0615755

Country of ref document: EP

2009-12-15

REN

Ceased due to non-payment of the annual fee